ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the ...

Substance use occurs more often in blue-collar and service industry jobs, but comprehensive policies and supportive ...

President Donald Trump will welcome Bahrain Crown Prince Salman bin Hamad Al Khalifa to the White House on Wednesday. It’s ...

Thirteen people are charged following the return of 12 indictments alleging more than a dozen charges against these ...

The administration's embrace of psychedelics has sparked both excitement as well as concern from those in the field.

Nasus Pharma has filed to raise $11M in an IPO of its ordinary shares, according to SEC F-1 registration. Read why my outlook ...

A new Texas law that will provide up to $50 million to study ibogaine reflects growing government interest in psychedelic ...

Nalu Medical, Inc., a leader in miniaturized neuromodulation therapies, is pleased to announce that Aetna Inc. has issued an updated medical policy designating the Nalu Neurostimulation System as ...